Las repeticiones palindrómicas cortas agrupadas y regularmente espaciadas (CRISPR, por
sus siglas en inglés), junto con la endonucleasa Cas, forman el complejo CRISPR/Cas. …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive
change, with variants conferring advantage rapidly becoming dominant lineages, eg, B.…

Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current
vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. …

SARS-CoV-2 has caused over 2 million deaths in little over a year. Vaccines are being
deployed at scale, aiming to generate responses against the virus spike. The scale of the …

Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency
use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) …

The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines
and therapeutics will depend on understanding viral immunity. We studied T cell memory …

Background: The COVID-19 pandemic caused> 1 million infections during January-March
2020. There is an urgent need for reliable antibody detection approaches to support diagnosis…

The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
began when the first sequence was published, and this forms the basis for …

Background The progression and geographical distribution of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection in the United Kingdom (UK) and elsewhere is …

Infections with dengue virus (DENV) and Zika virus (ZIKV) can induce cross-reactive antibody
responses. Two immunodominant epitopes—one to precursor membrane protein and one …